期刊文献+

吉非替尼一线治疗细支气管肺泡癌致出血性膀胱炎(英文)

Unusual side effect and dramatic response from gefitinib as first-line use in a male-patient with bronchioloalveolar carcinoma
下载PDF
导出
摘要 A 45-year-old man with bronchioloalveolar carcinoma was treated with gefitinib. The most severe side effect was hemorrhagic cystitis but he had a dramatic response. A 45-year-old man with bronchioloalveolar carcinoma was treated with gefitinib. The most severe side effect was hemorrhagic cystitis but he had a dramatic response.
机构地区 Department of Oncology
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2007年第6期601-602,共2页 中德临床肿瘤学杂志(英文版)
关键词 癌细胞 膀胱炎 肿瘤 治疗方法 bronchioloalveolar cell carcinoma gefitinib hemorrhagic cystitis
  • 相关文献

参考文献5

  • 1Argiris A, Mittal N. Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer. Lung Cancer, 2004, 43: 317-322.
  • 2Yang CH, Shih JY, Chen KC, et al. Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced non-small cell lung cancer. Cancer, 2006, 107: 1873-1882.
  • 3Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol, 2004, 22: 1103-1109.
  • 4Hirsch FR, Varella-Garcia M, Bunn PA Jr, et al. Molecular predictors of outcome with gefitinib in a phase Ⅲ placebo-controlled study in advanced non-small-cell lung cancer. J Clin Oncol, 2006, 24: 5034- 5042.
  • 5Janne PA, Engelman JA, Johnson BE. Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology. J Clin Oncol, 2005, 23: 3227-3234.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部